Marie-Pascale Graas

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer

José Baselga, Patricia Gómez, Richard Greil et al. · Journal of Clinical Oncology · 2013 · 350 citations · Full text

Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma

Jacques De Grève, Teresa Morán, Marie-Pascale Graas et al. · Lung Cancer · 2015 · 86 citations

Medicine, Lung Adenocarcinoma, Pathology +6

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Advanced Ovarian Cancer, Medicine, Pharmacology +9

The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer

Andrew Wardley, Javier Cortés, Louise Provencher et al. · Breast Cancer Research and Treatment · 2021 · 30 citations · Full text

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

Guy Jérusalem, Subrina Farah, Anne-Catherine Courtois et al. · Annals of Oncology · 2021 · 30 citations · Full text

Breast Oncology, Medicine, Pharmacology +7